1. JNK1 negatively controls antifungal innate immunity by suppressing CD23 expression
- Author
-
Bin Zhang, Tianming Luo, Shilei Zhang, Chen Dong, Xin Lin, Xueqiang Zhao, Changying Jiang, Yahui Guo, Mien Chie Hung, Xin-Ming Jia, and Qing Chang
- Subjects
0301 basic medicine ,Antifungal Agents ,Neutrophils ,Immunoblotting ,Nitric Oxide ,Polymerase Chain Reaction ,Article ,Monocytes ,General Biochemistry, Genetics and Molecular Biology ,Microbiology ,Mice ,03 medical and health sciences ,Immune system ,Phagocytosis ,Downregulation and upregulation ,Immunity ,Candida albicans ,Animals ,Humans ,Mitogen-Activated Protein Kinase 8 ,Promoter Regions, Genetic ,Protein Kinase Inhibitors ,Mice, Knockout ,Innate immune system ,NFATC Transcription Factors ,biology ,Receptors, IgE ,Macrophages ,Fungi ,Candidiasis ,CD23 ,Dendritic Cells ,General Medicine ,biology.organism_classification ,Immunity, Innate ,Corpus albicans ,3. Good health ,030104 developmental biology ,Mycoses ,Gene Expression Regulation ,Immunology ,NIH 3T3 Cells ,Cytokines ,Signal transduction ,Reactive Oxygen Species - Abstract
Opportunistic fungal infections are a leading cause of death among immune-compromised patients, and there is a pressing need to develop new antifungal therapeutic agents because of toxicity and resistance to the antifungal drugs currently in use. Although C-type lectin receptor- and Toll-like receptor-induced signaling pathways are key activators of host antifungal immunity, little is known about the mechanisms that negatively regulate host immune responses to a fungal infection. Here we found that JNK1 activation suppresses antifungal immunity in mice. We showed that JNK1-deficient mice had a significantly higher survival rate than wild-type control mice in response to Candida albicans infection, and the expression of JNK1 in hematopoietic innate immune cells was critical for this effect. JNK1 deficiency leads to significantly higher induction of CD23, a novel C-type lectin receptor, through NFATc1-mediated regulation of the CD23 gene promoter. Blocking either CD23 upregulation or CD23-dependent nitric oxide production eliminated the enhanced antifungal response found in JNK1-deficient mice. Notably, JNK inhibitors exerted potent antifungal therapeutic effects in both mouse and human cells infected with C. albicans, indicating that JNK1 may be a therapeutic target for treating fungal infection.
- Published
- 2017
- Full Text
- View/download PDF